Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, U.S.A.
Department of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, U.S.A.
Biochem Soc Trans. 2018 Feb 19;46(1):37-42. doi: 10.1042/BST20170236. Epub 2017 Dec 1.
Mutations in the lamin A/C gene () encoding intermediate filament proteins associated with the inner nuclear membrane cause diseases known as laminopathies. Most mutations cause dilated cardiomyopathy with variable skeletal muscular dystrophy. Cell signaling abnormalities have been discovered in hearts of mouse models of cardiomyopathy caused by mutations that contribute to pathogenesis. These include abnormally increased signaling by extracellular signal-regulated kinase 1 and kinase 2 and other mitogen-activated protein kinases, protein kinase B/mammalian target of rapamycin complex 1 and transforming growth factor-β. Preclinical research suggests that specific inhibitors of these abnormally activated cell signaling pathways may be useful in treating human patients with this disease.
基因突变()编码与核内膜相关的中间丝蛋白,导致称为层粘连蛋白病的疾病。大多数突变导致扩张型心肌病,伴有不同程度的骨骼肌病。在由突变引起的心肌病的小鼠模型心脏中发现了细胞信号异常,这些异常信号有助于发病机制。这些包括细胞外信号调节激酶 1 和激酶 2 和其他有丝分裂原激活的蛋白激酶、蛋白激酶 B/雷帕霉素靶蛋白复合物 1 和转化生长因子-β的信号异常增加。临床前研究表明,这些异常激活的细胞信号通路的特定抑制剂可能对治疗患有这种疾病的人类患者有用。